Jonathan Dante Nahas, MD
Gastroenterology
Accepting new patients
Sees patients age 18 and up
Penn Gastroenterology Perelman
View 1 additional location
Make an appointmentCall 215-349-8222
Penn Medicine Provider

About me

  • Assistant Professor of Clinical Medicine (Gastroenterology)

Education and training

  • Medical School: University of Miami
  • Residency: Mount Sinai Medical Center
  • Residency: Montefiore Medical Center

What my patients think about me

Average Rating

271 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

November 2025
he's very informative
October 2025
very professional
October 2025
personable, answered questions, asked my opinion, good listener
October 2025
pleasant and professional interaction

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Nahas is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Goyal T, Kaplan D, Nahas J Terlipressin Use Leads to a Significantly Reduced Creatinine Among hospitalized patients with Hepatorenal Syndrome when Compared with Midodrine/Octreotide in a Real-World Experience , AASLD Annual Meeting, Washington, DC: 2025

Nahas J, Accime B, Bittermann T, Cerra C, Goswami Banerjee A, Johnson K, Maggiaro R, Patrick E, Weinberg E, Weinrieb R, Serper M A Blueprint for Multidisciplinary Care for Alcohol-Associated Liver Disease Across Transplant Pathway: Structure, MAUD Utilization, and Early Outcomes , AASLD Annual Meeting, Washington, DC: 2025

Seija L, Keddem S, Schachter A, Ahluwalia V, Guevara J, Nahas J, Serper M, Schapira M, Klaiman T, Weinberg E, Weinrieb R, Goswami Banerjee A, Bittermann T Integrated Liver Transplant Engagement & Recovery Network: A Person-Centered Approach to Alcohol-Associated Liver Disease , AASLD Annual Meeting, Washington, DC: 2025

Vadaketh J, Saqlain J, Panchal S, Nahas J, Mitchell O Experience and Confidence of Gastroenterology Faculty and Fellows in Placement of Balloon Tamponade Devices in Acute Variceal Hemorrhage , AASLD Annual Meeting, Washington, DC: 2025

Goyal T, Khanna T, Kaplan D, Nahas J Terlipressin Is Associated With Decreased Renal Replacement Therapy Compared With Midodrine/Octreotide Among Patients With Hepatorenal Syndrome , ACG Annual Meeting, Phoenix, AZ: 2025

Nahas J Alcohol-Associated Liver Diseases Diagnosis and Management , Penn Medicine Physician Interviews podcast: 2025

DeSousa A, Goyal T, Kaplan D, Nahas J Terlipressin Is Associated with Decreased Healthcare Resource Utilization Compared with Midodrine/Octreotide Among Patients with Hepatorenal Syndrome , AASLD Annual Meeting, San Diego, CA: 2024

Goswami A, Weinberg E, Coraluzzi E, Bittermann T, Nahas J, Addis S, Weinrieb R, Serper M A Tailored Virtual Program for Alcohol Use Disorder Treatment Among Liver Transplant Candidates and Recipients Is Feasible and Associated With Lower Post-Transplant Relapse , Clinical Transplantation, 38(7): 2024

Weinberg EM, Goswami Banerjee A, Bittermann T, Nahas J, Coraluzzi L, Addis S, Weinrieb R, Serper M Total Recovery-LT: A Novel Program for Alcohol Use Disorder Treatment among Liver Transplant Candidates and Recipients , American Transplant Congress Annual Meeting, Philadelphia, PA: 2024

Winters AC, Nathani RR, Bowman CA, Nahas J, Schiano TD, Florman SS, Im GY Universal alcohol biomarker monitoring improves drinking detection and accountability during evaluation for liver transplantation , Liver Transplantation, 30(3): 2024,331-333